Vulnerabilities/IBM/CVE-2026-123218
CVE-2026-123218: IBM Aspera Faspex Incorrect Authorization Vulnerability
CISA KEV entry · Last checked 15 Nov 2026, 13:39 UTC
Exploitation confirmedFix: Unknown
IBM Aspera Faspex contains an incorrect authorization vulnerability that could allow an authenticated user to craft a specific message to bypass authorization, causing privilege escalations.
Recommended action
Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.
CISA due date 12 Nov 2026 · CWE-863
Am I affected?
| Product | Affected versions | Fixed in |
|---|---|---|
| Aspera Faspex | 5.0.0 to 5.0.19 | Unknown |
No source states a fixed version. Check the vendor advisory below.
Before you patch
Restart
See vendor guidance.Known issues
Check release notes.Verification
Confirm installed version.Timeline
- 9 Nov 2026 · Added to CISA KEV
- 12 Nov 2026 · CISA due date
Sources checked
| CISA KEV | 15 Nov 2026, 13:39 UTC |
| CVE List v5 | 10 Nov 2026, 14:32 UTC |
| NVD | 15 Nov 2026, 13:39 UTC |
| FIRST EPSS | 15 Nov 2026, 13:39 UTC |
Data from CISA, MITRE, NVD and FIRST. Sources and licences.
Wrong affected version, fix or exploitation status? Report a correction. Include the vendor source if you have it.